Understanding the genome is not enough

It's time to do something about it.

Mote's disruptive technology draws together the disciplines of genome editing, in vitro evolution and synthetic biology.

We are developing a suite of highly engineered proteins and delivery systems to enable safe, predictable down-to-the-basepair editing of the genome in adult humans. With essentially zero off-target effects and predictable insertion, deletion and alteration of genomic sequences, these tools offer therapeutic and preventative potentials far beyond CRISPR.